Blog

IND Filed for Gene Therapy to Treat Scleroderma – AJMC.com Managed Markets Network

IND Filed for Gene Therapy to Treat Scleroderma
AJMC.com Managed Markets Network
If eventually approved, FCX-013 will provide a new therapeutic option for patients with scleroderma. Currently available treatments are symptomatic and supportive in nature; systemic or topical corticosteroids may be used, and light therapy or physical

2018-02-11 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.